Szabó G, Bátkai S, Bährle S, Dengler T J, Vahl C F, Zimmermann R, Hagl S
Department of Cardiac Surgery, University of Heidelberg, Germany.
J Cardiovasc Pharmacol. 1998 Feb;31(2):221-30. doi: 10.1097/00005344-199802000-00007.
Global myocardial ischemia and reperfusion injury play a major role in early postoperative graft dysfunction. In this study, the influence of nitric oxide (NO) on reperfusion injury and catecholamine sensitivity after ischemia was investigated in a heterotopic rat heart-transplantation model. After a 1-h ischemic preservation, reperfusion was started either after application of saline vehicle (control, n = 8) or nitro-L-arginine methyl ester (L-NAME; 10 mg/kg, n = 8) for inhibition of NO synthesis or NO-precursor L-arginine (L-Arg; 40 mg/kg, n = 8), or L-NAME plus L-Arg (n = 8), respectively. After 60 min of reperfusion, continuous dobutamine infusion (5 microg/kg/min) was started. Myocardial blood flow was assessed by the hydrogen-clearance method. An intraventricular balloon was used to measure pressure-volume relations: peak left ventricular pressure, the rate of pressure development (dP/dt), end-diastolic pressure, and isovolumic relaxation constant. Myocardial blood flow was significantly reduced after L-NAME and increased after L-Arg in comparison with control (p < 0.05). The L-NAME group showed decreased systolic and diastolic functional recovery in comparison with control. Simultaneous infusion of L-Arg and L-NAME reversed these effects. L-Arg alone led to a further improvement of cardiac functional recovery. Whereas myocardial blood flow remained unchanged in the L-NAME group with dobutamine infusion, it significantly increased in the control group (p < 0.05). L-Arg antagonized this effect of L-NAME. Dobutamine increased peak left ventricular pressure and dP/dt and shortened the isovolumic relaxation constant in all groups; however, the changes of systolic hemodynamic indices were significantly smaller in the L-NAME group (p < 0.05) and significantly higher in the L-Arg group (p < 0.05). These results indicate that (a) NO production within the graft during reperfusion has a significant beneficial effect on graft function, and (b) NO formation may play an important role in beta-adrenergic responses after heart transplantation.
全球心肌缺血再灌注损伤在术后早期移植物功能障碍中起主要作用。在本研究中,在异位大鼠心脏移植模型中研究了一氧化氮(NO)对缺血后再灌注损伤和儿茶酚胺敏感性的影响。经过1小时的缺血保存后,分别在应用生理盐水载体(对照组,n = 8)或硝基-L-精氨酸甲酯(L-NAME;10 mg/kg,n = 8)以抑制NO合成,或NO前体L-精氨酸(L-Arg;40 mg/kg,n = 8),或L-NAME加L-Arg(n = 8)后开始再灌注。再灌注60分钟后,开始持续输注多巴酚丁胺(5μg/kg/分钟)。通过氢清除法评估心肌血流量。使用心室内球囊测量压力-容积关系:左心室峰值压力、压力上升速率(dP/dt)、舒张末期压力和等容舒张常数。与对照组相比,L-NAME处理后心肌血流量显著降低,L-Arg处理后心肌血流量增加(p < 0.05)。与对照组相比,L-NAME组的收缩和舒张功能恢复降低。同时输注L-Arg和L-NAME可逆转这些效应。单独使用L-Arg可进一步改善心脏功能恢复。在输注多巴酚丁胺的L-NAME组中,心肌血流量保持不变,而在对照组中显著增加(p < 0.05)。L-Arg拮抗L-NAME的这种作用。多巴酚丁胺增加了所有组的左心室峰值压力和dP/dt,并缩短了等容舒张常数;然而,L-NAME组的收缩血流动力学指标变化显著较小(p < 0.05),而L-Arg组显著较高(p < 0.05)。这些结果表明:(a)再灌注期间移植物内产生的NO对移植物功能具有显著的有益作用;(b)NO的形成可能在心脏移植后的β-肾上腺素能反应中起重要作用。